sn 38 has been researched along with Benign Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumlová, B; Bigg, DC; Chaumeron, S; Constant, JF; Greene, AE; Grillet, F; Kanazawa, A; Prévost, G | 1 |
Akiyama, Y; Ando, Y; Fujita, K; Hirose, T; Ichikawa, W; Ishida, H; Kawara, K; Miwa, K; Miya, T; Mizuno, K; Nagashima, F; Narabayashi, M; Saji, S; Sasaki, Y; Sugiyama, M; Sunakawa, Y; Yamamoto, W; Yamashita, K | 1 |
Benetti, E; Centamore, A; Collina, S; Della Volpe, S; Martino, E; Sakaj, M; Sala, A; Terribile, E | 1 |
1 review(s) available for sn 38 and Benign Neoplasms
Article | Year |
---|---|
The long story of camptothecin: From traditional medicine to drugs.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camptotheca; Camptothecin; DNA Topoisomerases, Type I; Humans; Medicine, Traditional; Neoplasms; Structure-Activity Relationship | 2017 |
1 trial(s) available for sn 38 and Benign Neoplasms
Article | Year |
---|---|
Delayed elimination of SN-38 in cancer patients with severe renal failure.
Topics: Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Female; Genotype; Glucuronides; Glucuronosyltransferase; Humans; Irinotecan; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Prospective Studies; Renal Dialysis; Renal Insufficiency | 2011 |
1 other study(ies) available for sn 38 and Benign Neoplasms
Article | Year |
---|---|
Synthesis and bioevaluation of 22-hydroxyacuminatine analogs.
Topics: Antineoplastic Agents; DNA Topoisomerases, Type I; Humans; Indolizines; Molecular Structure; Neoplasms; Quinolines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 2008 |